Christopher Senner

Christopher Senner

Director of Finance/CFO at EXELIXIS, INC.

Net worth: 56 M $ as of 29/09/2026

58 year
Health Technology
Consumer Services

Profile

Currently, Christopher J. Senner occupies the position of Chief Financial Officer & Executive Vice President of Exelixis, Inc. Mr. Senner is also on the board of Cortexyme, Inc. He previously occupied the position of Vice President-Finance at Gilead Sciences, Inc. and Chief Financial Officer of Wyeth Pharmaceuticals LLC. Mr. Senner received an undergraduate degree from Bentley University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/05/2026 955,040 ( 0.39% ) 56 M $ 29/09/2026
28/07/2026 0 ( -.--% ) - $ 29/09/2026

Christopher Senner active positions

CompaniesPositionStart
EXELIXIS, INC. Director of Finance/CFO 14/07/2015

Former positions of Christopher Senner

CompaniesPositionEnd
IRULYA THERAPEUTICS INC. Director/Board Member 07/10/2026
GILEAD SCIENCES, INC. Corporate Officer/Principal 30/06/2015
Director of Finance/CFO 31/10/2009
Director of Finance/CFO -
See the detail of Christopher Senner's experience

Education of Christopher Senner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Christopher Senner